Dr. Gary Blick, MD

Dr. Blick practices at Quest Diagnostics Nichols Institute, Inc. in Rockville, Maryland.

Dr. Blick's NPI, 1598837957, was assigned on November 14, 2006. Dr. Blick graduated from University of Miami, Miller School of Medicine in 1984. Dr. Blick's Connecticut license number on file is 027524.

Dr. Blick's primary practice is Quest Diagnostics Nichols Institute, Inc., at 6111 Executive Blvd, Rockville, MD 20852 in Montgomery County. The practice phone is (703) 802-6900.

Dr. Blick's primary practice is Quest Diagnostics Nichols Institute, Inc. in Rockville, Maryland. Dr. Blick is also affiliated with Yale New Haven Hospital. The medical group on file is Ally Wellness. Dmand AI also links Dr. Blick to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blick practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Blick's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Blick is board certified in hiv specialist by the American Academy of HIV Medicine. Dmand AI has Dr. Blick's licenses on file in 3 states: Connecticut, Rhode Island and New York.

Dmand AI lists hiv/aids, lyme disease and UTI among the conditions Dr. Blick treats.

CMS data shows 190 Medicare services from Dr. Blick across 4 procedure codes in 2024, for 42 Medicare patients. Medicare paid $10,060 for them. Every service was in an office.

CMS counts 42 Medicare patients who saw Dr. Blick in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 40% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Blick's median patient age at 61, with 14% women.

In 2024, Dr. Blick wrote 6,782 Medicare Part D claims for 121 patients. 64% of them were for generic drugs. CMS names the drug for 5,997 of them, across 125 drugs with 11 or more claims each, at $5,539,747 in total drug cost. In 2023, CMS named 6,212 claims across 132 drugs.

Dr. Blick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Blick as offering telehealth.

Dmand AI links 30 papers to Dr. Blick, published from 2011 to 2024. 2011 was the busiest year, with 6. The most frequent topics are HIV Infections, Hypogonadism and Testosterone. Dr. Blick has published most often in Postgrad Med. Dr. Blick's most frequent co-authors are Rajib Kumar Bhattacharya, MD, Mohit Khera, MD and Martin M. Miner, MD.

Dmand AI links Dr. Blick to 12 clinical trials, 3 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include HIV Infections, Lentivirus Infections and Acquired Immunodeficiency Syndrome. Sangamo Therapeutics sponsors the most, 3.

CMS Open Payments shows 998 general payments to Dr. Blick from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. ViiV Healthcare Company paid the most, $685,215.

Dr. Blick graduated from University of Miami, Miller School of Medicine in 1984. Dr. Blick is a member of American Academy of HIV Medicine, AMA, CT State Medical Society, Fairfield County Medical Association, HIV Medical Association and International AIDS Society.

Dr. Blick is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.